|
|
|
|
|
L’historique des informations financières est fourni par Reuters. Axcan Pharma Inc. ne fait aucune représentation ni garantie par rapport à ces informations et n’accepte aucunement la responsabilité pour les informations supplémentaires, les amendements ou les mises à jour.
Disponible en anglais seulement
Quarterly Balance Sheet
View Annual
In Millions of U.S. Dollars
(except for per share items)
|
Quarter Ending
31 Dec 07
|
Quarter Ending
31 Dec 07
|
Quarter Ending
30 Sep 07
|
 |
Current Assets |
|
| |
Cash & Equivalents |
310.9 |
310.9 |
179.7 |
| |
Short Term Investments |
6.2 |
6.2 |
130.0 |
| |
Cash and Short Term Investments |
317.1 |
317.1 |
309.6 |
| |
Accounts Receivable (Trade), Net |
43.0 |
43.0 |
36.7 |
| |
Total Receivable, Net |
55.8 |
55.8 |
46.8 |
| |
Total Inventory |
30.4 |
30.4 |
26.7 |
| |
Prepaid Expenses |
4.0 |
4.0 |
3.1 |
| |
Other Current Assets, Total |
17.0 |
17.0 |
16.0 |
 |
TotalTotal Current Assets |
424.2 |
424.2 |
402.1 |
| |
Assets |
|
| |
Property/Plant/Equipment - Total Cost |
– |
– |
– |
| |
Accum. Deprec. - Total |
– |
– |
– |
| |
Property/Plant/Equip. - Net Total |
32.3 |
32.3 |
31.2 |
| |
Goodwill, Net |
27.5 |
27.5 |
27.5 |
| |
Intangibles, Net |
366.6 |
366.6 |
367.2 |
| |
Long Term Investments |
– |
– |
– |
| |
Other Long Term Assets, Total |
5.6 |
5.6 |
4.6 |
| |
TotalTotal Assets |
856.1 |
856.1 |
832.6 |
| |
Current Liabilities |
|
| |
Accounts Payable |
– |
– |
– |
| |
Accrued Expenses |
– |
– |
– |
| |
Notes Payable / Short Term Debt |
– |
– |
– |
| |
Current Port. LT Debt / Capital Leases |
0.4 |
0.4 |
0.5 |
| |
Other Current liablities, Total |
19.4 |
19.4 |
21.0 |
| |
TotalTotal Current Liabilities |
99.0 |
99.0 |
104.7 |
| |
Long Term Debt |
|
| |
Long Term Debt |
0.1 |
0.1 |
0.1 |
| |
Capital Lease Obligations |
– |
– |
– |
| |
TotalTotal Long Term Debt |
0.1 |
0.1 |
0.1 |
| |
Total Debt |
0.5 |
0.5 |
0.6 |
| |
Liabilities |
|
| |
Deferred Income Tax |
38.4 |
38.4 |
37.6 |
| |
Minority Interest |
– |
– |
– |
| |
TotalTotal Liabilities |
137.4 |
137.4 |
142.4 |
| |
Equity |
|
| |
Redeemed Preferred Stock, Total |
– |
– |
– |
| |
Preferred Stock (Non Redeemable) |
– |
– |
– |
| |
Common Stock, Total |
396.1 |
396.1 |
395.9 |
| |
Additional Paid-In Capital |
10.1 |
10.1 |
9.1 |
| |
Retained Earnings / Accum. Deficit |
271.7 |
271.7 |
249.4 |
| |
Treasury Stock Common ($ Amount) |
– |
– |
– |
| |
Other Equity, Total |
40.8 |
40.8 |
35.8 |
| |
TotalTotal Equity |
718.7 |
718.7 |
690.2 |
| |
Total Liability & Shareholders' Equity |
856.1 |
856.1 |
832.6 |
| |
Equity |
|
| |
S/O-Common Stock |
55.4 |
55.4 |
55.4 |
| |
TotalTotal Common Shares Outstanding |
55.4 |
55.4 |
55.4 |
| |
Employees |
– |
– |
– |
|
|
|
|
|
|
|
| |
|
|
|
